Phibro Animal Health (NASDAQ:PAHC) Stock Price Expected to Rise, Barclays Analyst Says

Phibro Animal Health (NASDAQ:PAHC) had its price target raised by Barclays from $13.00 to $20.00 in a research note released on Tuesday,Benzinga reports. They currently have an underweight rating on the stock.

Several other equities analysts have also commented on the stock. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target for the company. Bank of America boosted their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $16.50.

Phibro Animal Health Trading Down 1.7 %

Shares of PAHC stock traded down $0.42 during mid-day trading on Tuesday, hitting $24.48. 33,821 shares of the company’s stock were exchanged, compared to its average volume of 156,978. The stock has a market cap of $991.44 million, a price-to-earnings ratio of 57.91, a PEG ratio of 0.66 and a beta of 0.51. The stock has a 50-day simple moving average of $22.68 and a two-hundred day simple moving average of $19.65. Phibro Animal Health has a fifty-two week low of $9.49 and a fifty-two week high of $25.98. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The firm had revenue of $273.16 million for the quarter, compared to analyst estimates of $262.44 million. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. Equities analysts expect that Phibro Animal Health will post 1.59 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 1.96%. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Insider Activity

In related news, Director E Thomas Corcoran purchased 5,000 shares of the firm’s stock in a transaction on Wednesday, September 4th. The stock was purchased at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the acquisition, the director now directly owns 25,000 shares in the company, valued at $500,500. The trade was a 25.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 50.07% of the company’s stock.

Institutional Trading of Phibro Animal Health

Hedge funds have recently made changes to their positions in the company. Brandes Investment Partners LP grew its holdings in Phibro Animal Health by 1.2% during the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock valued at $40,521,000 after purchasing an additional 29,071 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Phibro Animal Health by 5.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock valued at $13,005,000 after buying an additional 42,086 shares during the last quarter. Acadian Asset Management LLC grew its stake in shares of Phibro Animal Health by 6.3% during the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after acquiring an additional 42,299 shares in the last quarter. Dana Investment Advisors Inc. increased its position in shares of Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after acquiring an additional 75,546 shares during the last quarter. Finally, American Century Companies Inc. grew its stake in Phibro Animal Health by 119.6% during the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after purchasing an additional 189,068 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.